Lv31
330 积分 2025-01-09 加入
The immunotoxin targeting PRLR increases tamoxifen sensitivity and enhances the efficacy of chemotherapy in breast cancer
57分钟前
待确认
Why Does EGFR-Targeted Therapy Continue to Fail in Breast Cancer? From Mechanistic Deciphering to Novel Intervention Strategies
2个月前
已完结
Why Does EGFR-Targeted Therapy Continue to Fail in Breast Cancer? From Mechanistic Deciphering to Novel Intervention Strategies
2个月前
已关闭
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
5个月前
已完结
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
5个月前
已完结
Development of Dual-Receptor Lysosome-Targeting Chimeras for Protein Degradation
5个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
6个月前
已完结
The interferon regulatory factors and oncogenesis
7个月前
已完结
Ubiquitination modification: critical regulation of IRF family stability and activity
7个月前
已完结
The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2 mutated, non-amplified metastatic breast cancer
9个月前
已完结
皖公网安备34019202002308
